Jyong Biotech Ltd. (MENS)

Jyong Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	1.73	1.54	0.85
Research & Development	1.07	1.29	1.56
Operating Expenses	2.8	2.83	2.4
Operating Income	-2.8	-2.83	-2.4
Interest Expense / Income	0.7	0.76	0.83
Other Expense / Income	0.9	3.04	0.97
Pretax Income	-4.4	-6.63	-4.2
Net Income	-4.4	-6.63	-4.2
Free Cash Flow	-2.6	-3.22	-2.12
EBITDA	-3.57	-5.75	-3.25
Depreciation & Amortization	0.13	0.12	0.12
EBIT	-3.7	-5.87	-3.37

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).